here - Australian College of Veterinary Scientists
here - Australian College of Veterinary Scientists
here - Australian College of Veterinary Scientists
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
They concluded that ideal treatment would be early surgical removal <strong>of</strong> the lesion,<br />
followed by daily intravenous and topical administration <strong>of</strong> Amphotericin B, with<br />
periodical extirpation <strong>of</strong> small necrotic tracts as necessary. Cost and a fairly high risk<br />
<strong>of</strong> nephrotoxicity due to Amphotericin B may be a deterring factor and more<br />
recently some strains <strong>of</strong> Pythium have shown resistance to amphotericin B (Eaton<br />
1993).More recent information has cast serious doubt on the efficacy <strong>of</strong> parentral<br />
Amphoteracin B and parentral treatment is now questionable<br />
Local treatment:<br />
After surgical removal <strong>of</strong> the tumour, Amphotericin B (50g Amphotericin B in 10ml<br />
sterile water) + 10ml DMSO in gauze was applied and bandaged in place. Treatment<br />
is continued daily for at least 1 week.<br />
More recently a severe case involving bone lesions in a mare was treated by surgery<br />
followed by daily packing with Ketaconazole, Rifampin, DMSO and 2N HCI applied<br />
to the wound cavity under bandages pre-coated with 10% Povidone-iodine ointment<br />
to stop leaking <strong>of</strong> the initial dressing. Immunotherapy was used as an adjunct to<br />
treatment in this case (Eaton 1993).<br />
Originally the production <strong>of</strong> a phenolised vaccine manufactured by the<br />
department <strong>of</strong> Tropical <strong>Veterinary</strong> Science, Townsville, showed indications <strong>of</strong><br />
success in the treatment <strong>of</strong> early lesions. Results <strong>of</strong> vaccination compare favourably<br />
with surgery and when used in conjunction with surgery, has given very good results.<br />
This is given in 2ml doses weekly for 2-6 weeks. Lesions show some regressions in<br />
7-10 days after the first injection, but reaction at the injection site can be moderate to<br />
severe. Indications <strong>of</strong> successful treatment are reduction <strong>of</strong> pruritus, drying <strong>of</strong><br />
exudate, expulsion <strong>of</strong> 'kunkers', fibrosis <strong>of</strong> granuloma and eventually, complete<br />
epithelialization (Miller 1981).<br />
Recently two types <strong>of</strong> vaccines were produced (Newton & Ross 1993), one being<br />
that originally developed in 1981 by Miller who produced a vaccine prepared with<br />
killed sonicated whole-cell hypha antigen <strong>of</strong> P. insidiosum.<br />
A second vaccine prepared by precipitation <strong>of</strong> soluble antigen from Pythium growth<br />
medium showed a similar cure rate with less side effects at the injection site and<br />
reportedly has a longer shelf life (Mendoza et al 1992). Successful treatment depends<br />
on a number <strong>of</strong> factors such as the age <strong>of</strong> the horse, general physical condition,<br />
previous treatment, age/size/site <strong>of</strong> the lesion and whether t<strong>here</strong> is bony<br />
involvement. Young fresh lesions <strong>of</strong> 2 weeks duration responded very well to<br />
immunotherapy alone, but if present for more than 2 months, t<strong>here</strong> was a poor<br />
response to this treatment (Mendoza et al 1992).<br />
Horses with infection in the bone have mostly died, even though they have some<br />
clinical improvement with surgery and post-operative medical treatment (Alfaro &<br />
Mendoza 1990).<br />
102<br />
ACVSC Proceedings Dermatology Chapter Science Week 2005